BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 36352186)

  • 1. Comparison of 1-h with 3-h planar
    Saitou T; Aikawa T; Manabe O; Nagase A; Kudo T; Oyama-Manabe N
    Ann Nucl Med; 2023 Feb; 37(2):99-107. PubMed ID: 36352186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous Tc-99m PYP/Tl-201 dual-isotope SPECT myocardial imaging in patients with suspected cardiac amyloidosis.
    Tamarappoo B; Otaki Y; Manabe O; Hyun M; Cantu S; Arnson Y; Gransar H; Hayes SW; Friedman JD; Thomson L; Slomka P; Dey D; Vescio R; Patel J; Berman DS
    J Nucl Cardiol; 2020 Feb; 27(1):28-37. PubMed ID: 31172386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicenter Study of Planar Technetium 99m Pyrophosphate Cardiac Imaging: Predicting Survival for Patients With ATTR Cardiac Amyloidosis.
    Castano A; Haq M; Narotsky DL; Goldsmith J; Weinberg RL; Morgenstern R; Pozniakoff T; Ruberg FL; Miller EJ; Berk JL; Dispenzieri A; Grogan M; Johnson G; Bokhari S; Maurer MS
    JAMA Cardiol; 2016 Nov; 1(8):880-889. PubMed ID: 27557400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic value of heart-to-mediastinum ratio in
    Ikoma T; Ohtani H; Ohno K; Iguchi K; Suwa K; Sawada M; Tanahashi Y; Sakamoto A; Saotome M; Ichikawa S; Goshima S; Maekawa Y
    J Nucl Cardiol; 2023 Aug; 30(4):1374-1381. PubMed ID: 36547805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosing Transthyretin Cardiac Amyloidosis by Technetium Tc 99m Pyrophosphate: A Test in Evolution.
    Poterucha TJ; Elias P; Bokhari S; Einstein AJ; DeLuca A; Kinkhabwala M; Johnson LL; Flaherty KR; Saith SE; Griffin JM; Perotte A; Maurer MS
    JACC Cardiovasc Imaging; 2021 Jun; 14(6):1221-1231. PubMed ID: 33221204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inter-observer reproducibility and intra-observer repeatability in
    Singh V; Cuddy S; Kijewski MF; Park MA; Taylor A; Taqueti VR; Skali H; Blankstein R; Falk RH; Di Carli MF; Dorbala S
    J Nucl Cardiol; 2022 Apr; 29(2):440-446. PubMed ID: 32918247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic performance characteristics of planar quantitative and semi-quantitative parameters of Tc
    Pandey S; Teruya S; Rodriguez C; Deluca A; Kinkhabwala M; Johnson LL; Fine D; Sabogal N; Winburn M; Castillo M; Bhatia K; Malkovskaya R; Raiszadeh F; Kurian D; Miller EJ; Einstein AJ; Maurer MS; Ruberg FL
    J Nucl Cardiol; 2023 Aug; 30(4):1414-1419. PubMed ID: 36823486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of cardio-focal and chest reconstruction of technetium-99m pyrophosphate scintigraphy for diagnosis of transthyretin cardiac amyloidosis: a quality assurance study.
    Akincioglu C; Murthi M; Romsa J; Warrington J; Malhotra S
    J Nucl Cardiol; 2023 Dec; 30(6):2607-2614. PubMed ID: 37012525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of planar with tomographic pyrophosphate scintigraphy for transthyretin cardiac amyloidosis: Perils and pitfalls.
    Asif T; Gomez J; Singh V; Doukky R; Nedeltcheva A; Malhotra S
    J Nucl Cardiol; 2021 Feb; 28(1):104-111. PubMed ID: 32901418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transthyretin amyloid cardiomyopathy disease burden quantified using
    Watanabe S; Nakajima K; Toshima F; Wakabayashi H; Yoshida S; Yoneyama H; Komatsu J; Konishi T; Kinuya S
    J Nucl Cardiol; 2023 Dec; 30(6):2721-2735. PubMed ID: 37605060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Volumetric evaluation of
    Watanabe S; Nakajima K; Wakabayashi H; Yoneyama H; Yoshida S; Komatsu J; Konishi T; Inaki A; Kinuya S
    J Nucl Cardiol; 2022 Dec; 29(6):3102-3110. PubMed ID: 34907500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Echocardiographic indices of left ventricular function and filling pressure are not related to blood pool activity on pyrophosphate scintigraphy.
    Asif T; Gupta A; Murthi M; Soman P; Singh V; Malhotra S
    J Nucl Cardiol; 2023 Apr; 30(2):708-715. PubMed ID: 35578000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serial scanning with technetium pyrophosphate (
    Castaño A; DeLuca A; Weinberg R; Pozniakoff T; Blaner WS; Pirmohamed A; Bettencourt B; Gollob J; Karsten V; Vest JA; Chiuzan C; Maurer MS; Bokhari S
    J Nucl Cardiol; 2016 Dec; 23(6):1355-1363. PubMed ID: 26453570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (99m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses.
    Bokhari S; Castaño A; Pozniakoff T; Deslisle S; Latif F; Maurer MS
    Circ Cardiovasc Imaging; 2013 Mar; 6(2):195-201. PubMed ID: 23400849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Echocardiographic score for the screening of cardiac amyloidosis with positive 99m technetium pyrophosphate scintigraphy result.
    Nagai T; Horinouchi H; Hashimoto K; Ichiji T; Yoshioka K; Hashimoto J; Ikari Y
    Echocardiography; 2023 Jul; 40(7):634-641. PubMed ID: 37243310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of the Kumamoto criteria for prediction of
    Ochi Y; Kubo T; Baba Y; Ueda M; Miyagawa K; Noguchi T; Hirota T; Yamasaki N; Kitaoka H
    J Cardiol; 2021 Feb; 77(2):124-130. PubMed ID: 33132078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wild type cardiac amyloidosis: is it time to order a nuclear technetium pyrophosphate SPECT imaging study?
    Shen CP; Vanichsarn CT; Pandey AC; Billick K; Rubenson DS; Mohan RC; Heywood JT; Srivastava AV
    Int J Cardiovasc Imaging; 2023 Jan; 39(1):201-208. PubMed ID: 36598681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Technetium-99m-pyrophosphate imaging-based computed tomography-guided core-needle biopsy of internal oblique muscle in wild-type transthyretin cardiac amyloidosis.
    Takahashi K; Hiratsuka Y; Iwamura T; Sasaki D; Yamamura N; Kitazawa S; Ueda M; Morioka H; Okura T; Enomoto D; Uemura S; Kono T; Sakaue T; Ikeda S
    Amyloid; 2024 Mar; 31(1):12-21. PubMed ID: 37486102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Towards a Diagnosis of Cardiac Amyloidosis: Single Center Experience with
    Saleem M; Sadat B; Van Harn M; Ananthasubramaniam K
    Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837580
    [No Abstract]   [Full Text] [Related]  

  • 20. Follow-up Tc-99 m pyrophosphate cardiac scan for patients with transthyretin cardiac amyloidosis treated with tafamidis.
    Lee TH; Wang YF; Hu LH; Peng NJ; Chang CY; Huang WS
    Jpn J Radiol; 2023 Aug; 41(8):882-888. PubMed ID: 36920732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.